Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma-Reference-Cited by-同舟云学术

Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma

Published:1998-04 Issue:1 Volume:15 Page:44-49
ISSN:0736-0118
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Wu Jingjing,Caliendo Geralyn,Hu Xiao-Ping,Dutcher Janice P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy,Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF02787344.pdf

Reference18 articles.

1. Robbins Pathological Basis of Disease,1994

2. Belldegrun A, Abi-Ada AS, Figlin RA, de Kernion JB. Renal cell carcinoma: basic biology and current approaches to therapy.Seminar in Oncology 1991;18: 96–101.

3. Hawkins MJ. Immunotherapy with high dose interleukin 2. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds).Comprehensive Textbook of Genitourinary Oncology Williams & Wilkins: Baltimore 1996;248–255.

4. Sparano JA, Dutcher JP, Wiernik PH. Low dose interleukin 2 for advanced renal cell carcinoma. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds).Comprehensive Textbook of Genitourinary Oncology 1996; pp 256–276.

5. Elson PJ, Witte RS, Trump DL. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma.Cancer 1988;48: 7310–7313.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Cell Carcinoma with Sarcomatoid Features;Rare Kidney Tumors;2018-09-30

2. Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma;Journal for ImmunoTherapy of Cancer;2016-11-15

3. Targeted therapies and the treatment of non-clear cell renal cell carcinoma;Annals of Oncology;2013-07

4. Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component;Journal of Cancer Research and Clinical Oncology;2013-02-09

5. Sarcomatoid-variant Renal Cell Carcinoma;American Journal of Clinical Oncology;2011-10